Primary Care Policy

RARE DISEASE IN UK PRIMARYCARE: WHY “MORE EDUCATION”ISN’T ENOUGH

NICE IS ABOUT TO PRESCRIBE MORE MEDICINES - HERE'S WHY

For 26 years, NICE has used the same yardstick to decide whether a new medicine is worth funding: the cost-effectiveness threshold. From April 2026, that yardstick is changing for the first time, and prescribers will feel it.

The prescription conversation that just got more structured

Prescribing gabapentinoids, benzos and Z-drugs? The ending comes first now.

The safety circuit breaker: Redefining the diagnostic journey

The mandate is clear: If a diagnosis remains unsubstantiated or symptoms escalate after three appointments: Reflect, Review, and Rethink. - Jess's Rule. Three strikes and we rethink.

Are We Losing the Battle for Primary Care?

Where is the money really flowing in healthcare...